On my way to the Chester Beatty Laboratories The ICR. Warm, but a bit of an end of summer feel.

After a long, sector-wide effort calling on Government to ensure Horizon Europe association for our researchers, we are delighted it's finally here. This opens doors to collaboration 🤝 will attract the brightest minds🧑‍🔬and strengthen UK science keeping us on the world stage 🌍

International collaboration is at the heart of scientific research, including cancer research, so it is great news for UK scientists that the UK rejoins the EU Horizon research scheme. bbc.co.uk/news/uk-667377…

Come and join us at @ELRIG_UK Drug Discovery 2023 on 18-19 October in Liverpool, UK

It was with sadness that many former colleagues of Martin Rowlands - retired SSO of the The ICR received the news of his unexpected death last month! Many members of staff and students remembered him with fondness because Martin was a very kind and great colleague.

It is exciting to see the renewal of the longstanding collaboration of our Centre for Cancer Drug Discovery The ICR with Merck Healthcare KGaA (Merck Healthcare) to discover innovative small-molecule therapeutics for the treatment of cancer!

Dear Rt Hon Michelle Donelan - As Science Minister, I think you owe the UK science community an apology for this nasty propaganda which undermines the community you are charged with representing. RT if you agree...

👨‍🔬We’re thrilled that the ICR's Dr Rob van Montfort #FBPE 🇪🇺 and Prof Paul Workman will be presenting at the #DrugDiscovery23 Conference (@ELRIG_UK) on Thursday. The conference is focused on bringing new therapies from the lab to the patient. Read more and register⬇️ elrig.eventsair.com/dd23

📜👩‍🎓Applications are now open for our 2023/24 fully-funded #PhD studentships. Check out our PhD projects and apply⬇️⬇️ icr.ac.uk/studying-and-t…

Great to see the FDA approval of the AKT inhibitor capivasertib for the treatment of breast cancer. Congratulations to everyone from ICR, Astex Pharmaceuticals and AstraZeneca who were involved in its discovery! Fantastic that this drug will now be benefitting cancer patients!

Are you an expert in recombinant proten purification and are interested to work in cancer drug discovery? Check out our website: icr.ac.uk. We have two vacancies available in my team. jobs.icr.ac.uk/vacancies/837/…

Chatted to Prof Sir Mel Greaves tonight at an event, one of The ICR ‘s most celebrated scientists & a world leader in childhood leukemia research This man is amazing & I can’t believe more people in UK/world don’t know about his work or the work of The ICR Short 🧵

Are you interested in working at interface between protein degradation and cancer drug discovery? Please check out the Higher Scientific Officer position in recombinant protein production and biophysics in my team:jobs.icr.ac.uk/vacancies/962/…

🎉 Happy 25th Birthday to our Division of #StructuralBiology 🎉 They're celebrating with a conference at the The Royal Society, which was opened by the Head of Division, Professor Laurence Pearl 🔥💚🚣‍♀️🛶♊️

Lots of great talks at our conference to celebrate 25 years of Structural Biology The ICR.

M​atthew J. Rodrigues et al.: Specific radiation damage to halogenated inhibitors and ligands in protein–ligand crystal structures #RadiationDamage #ProteinLigandComplexes #HalogenatedLigand ... #IUCr journals.iucr.org/paper?S1600576…

Radiation damage to proteins in crystal structures is well studied but specific radiation damage to bound inhibitors is poorly documented. Pleased our study on radiation damage to halogenated inhibitors/ligands in protein crystal structures is out now:doi.org/10.1107/S16005…

Dear all, I am winding down my activities on X but you can follow me on Bluesky: @robvanmontfort.bsky.social